Keyphrases
Acute Myeloid Leukemia
28%
Adverse Events
15%
African American
12%
AIDS/HIV
24%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
16%
Antiretroviral Therapy
19%
Apoptosis
15%
Asthma
26%
Atrial Fibrillation
20%
Body Mass Index
13%
Breast Cancer
16%
Cardiovascular Disease
18%
Cardiovascular Risk
13%
Chemotherapy
21%
Chicago
12%
Chronic Kidney Disease
16%
Chronic Myeloid Leukemia
13%
Chronic Rhinosinusitis
9%
Clinical Outcomes
21%
Clinical Practice
11%
Clinical Practice Guidelines
14%
Clinical Trials
31%
Comorbidity
10%
Confidence Interval
56%
Coronary Artery Disease
13%
COVID-19
25%
Crohn's Disease
19%
Diabetes
21%
Disease Progression
11%
Echocardiographic
11%
Ejection Fraction
9%
Electronic Health Records
11%
Eosinophilic Esophagitis
11%
Eosinophils
13%
Fibrosis
9%
Gastroesophageal Reflux Disease
9%
Gene Expression
14%
Hazard Ratio
23%
Health Literacy
9%
Heart Failure
48%
Heart Failure with Preserved Ejection Fraction (HFpEF)
23%
Hematological Malignancies
11%
Hepatocellular Carcinoma
9%
High Dose
9%
High Risk
23%
HIV Infection
10%
HIV Patients
18%
Hospitalization
17%
Hospitalized Patients
9%
Human Immunodeficiency Virus Type 1 (HIV-1)
26%
Hypertension
15%
In Cancer
14%
Inflammation
17%
Inflammatory Bowel Disease
19%
Interferon-α (IFN-α)
17%
Kidney
13%
Left Ventricular Ejection Fraction
11%
Left Ventricular Function
18%
Leukemia
10%
Liver Transplantation
14%
Lung
16%
Macrophages
10%
Malignancy
10%
Melanoma
9%
Meta-analysis
14%
Metastatic Breast Cancer
11%
Myelodysplastic Syndrome
9%
Myocardial Infarction
12%
Obesity
20%
Odds Ratio
21%
Older Adults
21%
Oncology
9%
Overall Survival
25%
Pathophysiology
11%
Patients with Heart Failure
17%
Peripheral Arterial Disease
13%
Phase II Study
17%
Phase II Trial
20%
Physical Activity
10%
Placebo
27%
Plasminogen Activator inhibitor-1 (PAI-1)
9%
Progression-free Survival
12%
Prostate Cancer
13%
Quality of Life
15%
Randomized Clinical Trial
10%
Randomized Controlled Trial
15%
Randomized Trial
12%
Rheumatoid Arthritis
16%
Risk Factors
23%
Systemic Lupus Erythematosus
21%
Systemic Sclerosis
9%
T Cells
17%
Transcription Factor
9%
Transplantation
13%
Treatment Options
9%
Tumor
22%
Type 1 Diabetes Mellitus (T1DM)
15%
Type 2 Diabetes Mellitus (T2DM)
15%
Ulcerative Colitis
11%
United States
35%
Medicine and Dentistry
Acute Myeloid Leukemia
21%
Adverse Event
19%
Antiretroviral Therapy
11%
Apoplexy
10%
Arm
11%
Asthma
15%
Atherosclerosis
13%
Atrial Fibrillation
18%
Biological Marker
19%
Biopsy Technique
11%
Body Mass Index
13%
Breast Cancer
26%
Cancer
13%
Cancer Cell
8%
Cardiovascular Disease
23%
Cardiovascular System
24%
Chemotherapy
26%
Chronic Kidney Disease
15%
Chronic Rhinosinusitis
8%
Clinical Trial
32%
Clinician
21%
Cohort Analysis
19%
Cohort Effect
8%
Combination Therapy
15%
Comorbidity
10%
Congestive Heart Failure
59%
Coronary Artery Disease
16%
COVID-19
24%
Crohn's Disease
9%
Diabetes
26%
Diabetes Mellitus
10%
Diagnosis
24%
Diseases
100%
Drug Megadose
8%
Drug Therapy
22%
Echocardiography
14%
Ejection Fraction
15%
Electronic Health Record
9%
Emergency Department
8%
Eosinophilic Esophagitis
10%
Fibrosis
11%
Gastroesophageal Reflux
11%
Hazard Ratio
19%
Health Care
11%
Health Care Cost
16%
Heart Failure with Preserved Ejection Fraction
12%
Heart Left Ventricle Ejection Fraction
8%
Hematopoietic Cell
10%
Hemodynamic
12%
Hepatocellular Carcinoma
10%
Human Immunodeficiency Virus
45%
Immunity
11%
Immunosuppressive Treatment
8%
Immunotherapy
9%
In Vitro
10%
Infection
30%
Inflammatory Bowel Disease
11%
Injury
9%
Kidney Graft
8%
Liver Graft
10%
Liver Transplantation
13%
Lung
23%
Magnetic Resonance Imaging
11%
Malignant Neoplasm
42%
Maturity Onset Diabetes of the Young
11%
Medicine
8%
Melanoma
11%
Meta-Analysis
10%
Metastatic Carcinoma
12%
Myelodysplastic Syndrome
8%
Myocardial Infarction
11%
Neoplasm
38%
Nephropathy
9%
Odds Ratio
18%
Oncology
20%
Outpatient
10%
Overall Survival
25%
Pathophysiology
8%
Pediatrics
9%
Placebo
19%
Prevalence
24%
Primary Health Care
14%
Programmed Cell Death
9%
Progression Free Survival
12%
Prostate Cancer
17%
Pulmonary Hypertension
13%
Quality of Life
18%
Radiation Therapy
9%
Randomized Controlled Trial
12%
Receptor
9%
Recurrent Disease
12%
Reflux
9%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Surgery
13%
Systematic Review
14%
Systemic Lupus Erythematosus
13%
T Cell
11%
Targeted Therapy
9%
Transplantation
25%
Ulcerative Colitis
10%